NCT07618767

Brief Summary

This retrospective cohort study will examine shared neural mechanisms of social cognitive deficits in adults with autism spectrum disorder and adults with schizophrenia using existing clinical, behavioral, and neuroimaging data from National Taiwan University Hospital cohort studies. The study will include adults with autism spectrum disorder, adults with schizophrenia, and healthy control participants. Resting-state functional magnetic resonance imaging (MRI) and structural MRI data will be analyzed to estimate default mode network functional transition indices. These indices will be compared between diagnostic groups and examined in association with social cognitive and psychiatric symptom measures, including the Social Responsiveness Scale (SRS) and the Positive and Negative Syndrome Scale (PANSS) when applicable. No new participants will be recruited, and no intervention will be administered. The study will use previously collected data from 80 adults with autism spectrum disorder, 79 adults with schizophrenia, and 108 healthy controls.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
267

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Sep 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Sep 2025Dec 2027

Study Start

First participant enrolled

September 30, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2026

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

June 8, 2026

Status Verified

May 1, 2026

Enrollment Period

10 months

First QC Date

May 24, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

schizophreniaautism spectrum disorderfMRIsocial cognition

Outcome Measures

Primary Outcomes (1)

  • Default Mode Network mean functional state transition velocity, DMNμV

    DMNμV will be derived from resting-state functional MRI data. Multi-voxel activity patterns within the default mode network will be projected into a two-dimensional state space using multidimensional scaling. The Euclidean distance between consecutive functional states will be calculated, and the mean transition velocity across time points will be used as an index of default mode network functional state stability. Lower DMNμV indicates slower state transition and higher functional state stability.

    Baseline / retrospective assessment from pre-existing resting-state fMRI data

Secondary Outcomes (3)

  • Default Mode Network Root Mean Square of Successive Differences

    Baseline / retrospective assessment from existing resting-state fMRI data

  • Social Responsiveness Scale Score, SRS

    Baseline / retrospective assessment from existing source cohort records

  • Positive and Negative Syndrome Scale Score, PANSS

    Baseline / retrospective assessment from existing source cohort records

Study Arms (3)

Healthy controls

Autism Spectrum Disorder

Schizophrenia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This retrospective cohort study will use pre-existing clinical, behavioral, and neuroimaging data from adult participants who were previously enrolled in cohort studies conducted at National Taiwan University Hospital. The study population includes adults with autism spectrum disorder, adults with schizophrenia, and healthy control participants. Available data include structural MRI, resting-state functional MRI, and symptom or behavioral assessments relevant to social cognition and psychiatric symptoms, including the Social Responsiveness Scale and the Positive and Negative Syndrome Scale when applicable. No new participants will be prospectively recruited, and no intervention will be administered.

You may qualify if:

  • Previously enrolled in one of the source cohort studies approved by the institutional review board of National Taiwan University Hospital.
  • Adult participants belonging to one of the following groups:
  • Autism spectrum disorder group: participants with a clinical diagnosis of autism spectrum disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.
  • Schizophrenia group: participants with a clinical diagnosis of schizophrenia according to DSM-5 criteria.
  • Healthy control group: participants without a history of autism spectrum disorder, schizophrenia, or other major psychiatric or neurodevelopmental disorders according to available source cohort records.
  • Availability of resting-state functional MRI data acquired under the study MRI protocol.
  • For participants in the autism spectrum disorder group, availability of autistic trait or social functioning measures, such as the Social Responsiveness Scale, when used in symptom-association analyses.
  • For participants in the schizophrenia group, availability of psychiatric symptom measures, such as the Positive and Negative Syndrome Scale, when used in symptom-association analyses.

You may not qualify if:

  • Missing or incomplete MRI data.
  • Poor-quality MRI data due to severe artifacts, failed preprocessing, failed registration, or incomplete brain coverage.
  • Excessive head motion during resting-state fMRI that prevents reliable analysis.
  • Missing essential demographic or diagnostic information.
  • Missing required clinical or behavioral measures for specific association analyses.
  • Healthy controls with documented major psychiatric or neurodevelopmental disorders, if identified in source cohort records.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

SchizophreniaAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersChild Development Disorders, PervasiveNeurodevelopmental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2026

First Posted

June 1, 2026

Study Start

September 30, 2025

Primary Completion (Estimated)

July 23, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

June 8, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations